+91-22-489139092022-ലെ മികച്ച പ്രകടനം കാഴ്ചവെക്കുന്ന മ്യൂച്വൽ ഫണ്ടുകൾ
ചുവടെയുള്ള മാനദണ്ഡങ്ങൾ അടിസ്ഥാനമാക്കി ഞങ്ങൾ തിരഞ്ഞെടുത്തുമികച്ച പ്രകടനം നടത്തുന്ന മ്യൂച്വൽ ഫണ്ടുകൾ October, 2022. ഞങ്ങൾ ഫിൽട്ടർ ചെയ്ത ഫണ്ടുകൾ ഏറ്റവും കുറഞ്ഞത്
100 കോടിഎല്ലാ വിഭാഗങ്ങളിൽ നിന്നും മാനേജ്മെന്റിന് കീഴിലുള്ള ആസ്തികൾ.
Talk to our investment specialist
മാനദണ്ഡം
- AUM> 100 കോടി
- ഫണ്ടിന്റെ പ്രായം > 1 വർഷം
- എല്ലാ വിഭാഗങ്ങളിൽ നിന്നുമുള്ള ഫണ്ടുകൾ
- 1 മാസത്തെ റിട്ടേണുകളിൽ ക്രമീകരിച്ചു.
- ഫണ്ടുകളുടെ വിഭാഗങ്ങൾ
- ഇക്വിറ്റി
- കടം
- ഹൈബ്രിഡ്
- സ്വർണ്ണം
- ആഗോള ഫണ്ട്
മ്യൂച്വൽ ഫണ്ടുകളിൽ ഓൺലൈനിൽ എങ്ങനെ നിക്ഷേപിക്കാം?
Fincash.com-ൽ ആജീവനാന്ത സൗജന്യ നിക്ഷേപ അക്കൗണ്ട് തുറക്കുക.
നിങ്ങളുടെ രജിസ്ട്രേഷനും KYC പ്രക്രിയയും പൂർത്തിയാക്കുക
രേഖകൾ അപ്ലോഡ് ചെയ്യുക (പാൻ, ആധാർ മുതലായവ).കൂടാതെ, നിങ്ങൾ നിക്ഷേപിക്കാൻ തയ്യാറാണ്!
2022 ലെ മികച്ച 11 മികച്ച മ്യൂച്വൽ ഫണ്ടുകൾ
Fund NAV Net Assets (Cr) Min Investment Min SIP Investment 1 MO (%) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2024 (%) HDFC Long Term Advantage Fund Growth ₹595.168
↑ 0.28 ₹1,318 500 500 4.4 1.2 15.4 35.5 20.6 17.4 IDBI Nifty Index Fund Growth ₹36.2111
↓ -0.02 ₹208 5,000 500 3.7 9.1 11.9 16.2 20.3 11.7 IDBI Equity Advantage Fund Growth ₹43.39
↑ 0.04 ₹485 500 500 3.1 9.7 15.1 16.9 20.8 10 IDBI India Top 100 Equity Fund Growth ₹44.16
↑ 0.05 ₹655 5,000 500 3 9.2 12.5 15.4 21.9 12.6 SBI Healthcare Opportunities Fund Growth ₹469.706
↑ 4.29 ₹4,323 5,000 500 2.7 10.6 11 10.7 25 15.8 -3.5 IDBI Diversified Equity Fund Growth ₹37.99
↑ 0.14 ₹382 5,000 500 2.4 10.2 13.2 13.5 22.7 12 Kotak Global Emerging Market Fund Growth ₹40.482
↑ 1.34 ₹1,540 5,000 1,000 2.2 24.5 33.7 64.4 27 11.4 39.1 IDBI Hybrid Equity Fund Growth ₹17.1253
↓ -0.01 ₹179 5,000 500 2.1 7.8 9.8 12.1 14.4 7.1 UTI Healthcare Fund Growth ₹309.984
↓ -1.33 ₹1,144 5,000 500 2 9.8 8.9 9.9 26.1 13.9 -3.1 ICICI Prudential US Bluechip Equity Fund Growth ₹74.79
↑ 0.65 ₹3,607 5,000 100 1.9 1.4 4.5 21.1 13.7 11.1 15.8 Sundaram Equity Hybrid Fund Growth ₹135.137
↑ 0.78 ₹1,954 5,000 100 1.8 0.5 10.5 27.1 16 14.2 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 14 Jan 22 Research Highlights & Commentary of 11 Funds showcased
Commentary HDFC Long Term Advantage Fund IDBI Nifty Index Fund IDBI Equity Advantage Fund IDBI India Top 100 Equity Fund SBI Healthcare Opportunities Fund IDBI Diversified Equity Fund Kotak Global Emerging Market Fund IDBI Hybrid Equity Fund UTI Healthcare Fund ICICI Prudential US Bluechip Equity Fund Sundaram Equity Hybrid Fund Point 1 Upper mid AUM (₹1,318 Cr). Bottom quartile AUM (₹208 Cr). Lower mid AUM (₹485 Cr). Lower mid AUM (₹655 Cr). Highest AUM (₹4,323 Cr). Bottom quartile AUM (₹382 Cr). Upper mid AUM (₹1,540 Cr). Bottom quartile AUM (₹179 Cr). Lower mid AUM (₹1,144 Cr). Top quartile AUM (₹3,607 Cr). Upper mid AUM (₹1,954 Cr). Point 2 Established history (25+ yrs). Established history (15+ yrs). Established history (12+ yrs). Established history (14+ yrs). Established history (21+ yrs). Established history (12+ yrs). Established history (18+ yrs). Established history (9+ yrs). Oldest track record among peers (26 yrs). Established history (13+ yrs). Established history (25+ yrs). Point 3 Rating: 3★ (top quartile). Rating: 1★ (bottom quartile). Rating: 3★ (upper mid). Rating: 3★ (upper mid). Rating: 2★ (lower mid). Rating: 2★ (lower mid). Rating: 3★ (upper mid). Not Rated. Rating: 1★ (bottom quartile). Top rated. Rating: 2★ (lower mid). Point 4 Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Point 5 5Y return: 17.39% (top quartile). 5Y return: 11.74% (lower mid). 5Y return: 9.97% (bottom quartile). 5Y return: 12.61% (upper mid). 5Y return: 15.78% (top quartile). 5Y return: 12.03% (lower mid). 5Y return: 11.43% (lower mid). 5Y return: 7.09% (bottom quartile). 5Y return: 13.92% (upper mid). 5Y return: 11.14% (bottom quartile). 5Y return: 14.20% (upper mid). Point 6 3Y return: 20.64% (lower mid). 3Y return: 20.28% (lower mid). 3Y return: 20.84% (lower mid). 3Y return: 21.88% (upper mid). 3Y return: 24.99% (upper mid). 3Y return: 22.73% (upper mid). 3Y return: 27.02% (top quartile). 3Y return: 14.43% (bottom quartile). 3Y return: 26.12% (top quartile). 3Y return: 13.66% (bottom quartile). 3Y return: 16.03% (bottom quartile). Point 7 1Y return: 35.51% (top quartile). 1Y return: 16.16% (lower mid). 1Y return: 16.92% (upper mid). 1Y return: 15.39% (lower mid). 1Y return: 10.65% (bottom quartile). 1Y return: 13.54% (lower mid). 1Y return: 64.37% (top quartile). 1Y return: 12.06% (bottom quartile). 1Y return: 9.93% (bottom quartile). 1Y return: 21.10% (upper mid). 1Y return: 27.10% (upper mid). Point 8 Alpha: 1.75 (lower mid). 1M return: 3.68% (top quartile). Alpha: 1.78 (upper mid). Alpha: 2.11 (upper mid). Alpha: -1.64 (bottom quartile). Alpha: -1.07 (bottom quartile). Alpha: -2.33 (bottom quartile). 1M return: 2.10% (lower mid). Alpha: 1.95 (upper mid). Alpha: 3.03 (top quartile). 1M return: 1.80% (bottom quartile). Point 9 Sharpe: 2.27 (top quartile). Alpha: -1.03 (lower mid). Sharpe: 1.21 (upper mid). Sharpe: 1.09 (lower mid). Sharpe: -0.03 (bottom quartile). Sharpe: 1.01 (bottom quartile). Sharpe: 2.14 (upper mid). Alpha: -0.26 (lower mid). Sharpe: 0.24 (bottom quartile). Sharpe: 1.98 (upper mid). Alpha: 5.81 (top quartile). Point 10 Information ratio: -0.15 (upper mid). Sharpe: 1.04 (lower mid). Information ratio: -1.13 (bottom quartile). Information ratio: 0.14 (top quartile). Information ratio: -0.12 (upper mid). Information ratio: -0.53 (lower mid). Information ratio: -0.38 (lower mid). Sharpe: 1.03 (lower mid). Information ratio: -0.12 (upper mid). Information ratio: -1.59 (bottom quartile). Sharpe: 2.64 (top quartile). HDFC Long Term Advantage Fund
IDBI Nifty Index Fund
IDBI Equity Advantage Fund
IDBI India Top 100 Equity Fund
SBI Healthcare Opportunities Fund
IDBI Diversified Equity Fund
Kotak Global Emerging Market Fund
IDBI Hybrid Equity Fund
UTI Healthcare Fund
ICICI Prudential US Bluechip Equity Fund
Sundaram Equity Hybrid Fund
*ഇതിന്റെ ലിസ്റ്റ് ചുവടെയുണ്ട്മുൻനിര മ്യൂച്വൽ ഫണ്ടുകൾ 2022-ലെ സി.എംആസ്തി >= 100 കോടി
To generate long term capital appreciation from a portfolio that is predominantly in equity and equity related instruments Below is the key information for HDFC Long Term Advantage Fund Returns up to 1 year are on The investment objective of the scheme is to invest in the stocks and equity related instruments comprising the S&P CNX Nifty Index in the same weights as these stocks represented in the Index with the intent to replicate the performance of the Total Returns Index of S&P CNX Nifty index. The scheme will adopt a passive investment strategy and will seek to achieve the investment objective by minimizing the tracking error between the S&P CNX Nifty index (Total Returns Index) and the scheme. Research Highlights for IDBI Nifty Index Fund Below is the key information for IDBI Nifty Index Fund Returns up to 1 year are on The Scheme will seek to invest predominantly in a diversified portfolio of equity and equity related instruments with the objective to provide investors with opportunities for capital appreciation and income along with the benefit of income-tax deduction(under section 80C of the Income-tax Act, 1961) on their investments. Investments in this scheme would be subject to a statutory lock-in of 3 years from the date of allotment to be eligible for income-tax benefits under Section 80C. There can be no assurance that the investment objective under the scheme will be realized. Research Highlights for IDBI Equity Advantage Fund Below is the key information for IDBI Equity Advantage Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related Instruments of Large Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. Research Highlights for IDBI India Top 100 Equity Fund Below is the key information for IDBI India Top 100 Equity Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing in a diversified portfolio of Equity and Equity related Instruments across market capitalization. However there can be no assurance that the investment objective under the Scheme will be realized Research Highlights for IDBI Diversified Equity Fund Below is the key information for IDBI Diversified Equity Fund Returns up to 1 year are on The investment objective of the scheme is to provide long-term capital appreciation by investing in an overseas mutual fund scheme that invests in a diversified portfolio of securities as prescribed by SEBI from time to time in global emerging markets. Research Highlights for Kotak Global Emerging Market Fund Below is the key information for Kotak Global Emerging Market Fund Returns up to 1 year are on (Erstwhile IDBI Prudence Fund) The investment objective of the scheme would be to generate opportunities for capital appreciation along with income by investing in a diversified basket of equity and equity related instruments, debt and money market instruments. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for IDBI Hybrid Equity Fund Below is the key information for IDBI Hybrid Equity Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities (including ADRs/GDRs issued by Indian and foreign companies) of companies listed on New York Stock Exchange and/or NASDAQ. However, there can be no assurance that the investment objective of the Scheme will be realized. Research Highlights for ICICI Prudential US Bluechip Equity Fund Below is the key information for ICICI Prudential US Bluechip Equity Fund Returns up to 1 year are on (Erstwhile Sundaram Balanced Fund) The scheme seeks to generate capital appreciation and current income through a judicious mix of investments in equities and fixed income securities. Research Highlights for Sundaram Equity Hybrid Fund Below is the key information for Sundaram Equity Hybrid Fund Returns up to 1 year are on 1. HDFC Long Term Advantage Fund
HDFC Long Term Advantage Fund
Growth Launch Date 2 Jan 01 NAV (14 Jan 22) ₹595.168 ↑ 0.28 (0.05 %) Net Assets (Cr) ₹1,318 on 30 Nov 21 Category Equity - ELSS AMC HDFC Asset Management Company Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.25 Sharpe Ratio 2.27 Information Ratio -0.15 Alpha Ratio 1.75 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000
Purchase not allowed Returns for HDFC Long Term Advantage Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 4.4% 3 Month 1.2% 6 Month 15.4% 1 Year 35.5% 3 Year 20.6% 5 Year 17.4% 10 Year 15 Year Since launch 21.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Fund Manager information for HDFC Long Term Advantage Fund
Name Since Tenure Data below for HDFC Long Term Advantage Fund as on 30 Nov 21
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 2. IDBI Nifty Index Fund
IDBI Nifty Index Fund
Growth Launch Date 25 Jun 10 NAV (28 Jul 23) ₹36.2111 ↓ -0.02 (-0.06 %) Net Assets (Cr) ₹208 on 30 Jun 23 Category Others - Index Fund AMC IDBI Asset Management Limited Rating ☆ Risk Moderately High Expense Ratio 0.9 Sharpe Ratio 1.04 Information Ratio -3.93 Alpha Ratio -1.03 Min Investment 5,000 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 31 May 22 ₹10,694 31 May 23 ₹11,961 Returns for IDBI Nifty Index Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 3.7% 3 Month 9.1% 6 Month 11.9% 1 Year 16.2% 3 Year 20.3% 5 Year 11.7% 10 Year 15 Year Since launch 10.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Fund Manager information for IDBI Nifty Index Fund
Name Since Tenure Data below for IDBI Nifty Index Fund as on 30 Jun 23
Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 3. IDBI Equity Advantage Fund
IDBI Equity Advantage Fund
Growth Launch Date 10 Sep 13 NAV (28 Jul 23) ₹43.39 ↑ 0.04 (0.09 %) Net Assets (Cr) ₹485 on 30 Jun 23 Category Equity - ELSS AMC IDBI Asset Management Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.39 Sharpe Ratio 1.21 Information Ratio -1.13 Alpha Ratio 1.78 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 31 May 22 ₹10,725 31 May 23 ₹12,303 Returns for IDBI Equity Advantage Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 3.1% 3 Month 9.7% 6 Month 15.1% 1 Year 16.9% 3 Year 20.8% 5 Year 10% 10 Year 15 Year Since launch 16% Historical performance (Yearly) on absolute basis
Year Returns 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Fund Manager information for IDBI Equity Advantage Fund
Name Since Tenure Data below for IDBI Equity Advantage Fund as on 30 Jun 23
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 4. IDBI India Top 100 Equity Fund
IDBI India Top 100 Equity Fund
Growth Launch Date 15 May 12 NAV (28 Jul 23) ₹44.16 ↑ 0.05 (0.11 %) Net Assets (Cr) ₹655 on 30 Jun 23 Category Equity - Large Cap AMC IDBI Asset Management Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.47 Sharpe Ratio 1.09 Information Ratio 0.14 Alpha Ratio 2.11 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 31 May 22 ₹10,862 31 May 23 ₹12,182 Returns for IDBI India Top 100 Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 3% 3 Month 9.2% 6 Month 12.5% 1 Year 15.4% 3 Year 21.9% 5 Year 12.6% 10 Year 15 Year Since launch 14.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Fund Manager information for IDBI India Top 100 Equity Fund
Name Since Tenure Data below for IDBI India Top 100 Equity Fund as on 30 Jun 23
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 5. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (09 Jun 26) ₹469.706 ↑ 4.29 (0.92 %) Net Assets (Cr) ₹4,323 on 30 Apr 26 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 1.97 Sharpe Ratio -0.03 Information Ratio -0.12 Alpha Ratio -1.64 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 31 May 22 ₹9,195 31 May 23 ₹10,589 31 May 24 ₹15,169 31 May 25 ₹18,703 31 May 26 ₹20,547 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 2.7% 3 Month 10.6% 6 Month 11% 1 Year 10.7% 3 Year 25% 5 Year 15.8% 10 Year 15 Year Since launch 15.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 -3.5% 2023 42.2% 2022 38.2% 2021 -6% 2020 20.1% 2019 65.8% 2018 -0.5% 2017 -9.9% 2016 2.1% 2015 -14% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 15.01 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Apr 26
Equity Sector Allocation
Sector Value Health Care 88.63% Basic Materials 8.75% Asset Allocation
Asset Class Value Cash 2.56% Equity 97.38% Debt 0.07% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA12% ₹506 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹293 Cr 450,000 Acutaas Chemicals Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433495% ₹233 Cr 900,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Jan 26 | APOLLOHOSP5% ₹229 Cr 300,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH5% ₹223 Cr 2,250,000
↑ 150,000 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | ASTERDM4% ₹168 Cr 2,400,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002574% ₹166 Cr 720,000 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Jun 21 | TORNTPHARM3% ₹151 Cr 360,000 Anthem Biosciences Ltd (Healthcare)
Equity, Since 31 Jul 25 | ANTHEM3% ₹149 Cr 1,962,504
↑ 508 Aether Industries Ltd (Basic Materials)
Equity, Since 31 May 22 | AETHER3% ₹145 Cr 1,235,202
↓ -84,798 6. IDBI Diversified Equity Fund
IDBI Diversified Equity Fund
Growth Launch Date 28 Mar 14 NAV (28 Jul 23) ₹37.99 ↑ 0.14 (0.37 %) Net Assets (Cr) ₹382 on 30 Jun 23 Category Equity - Multi Cap AMC IDBI Asset Management Limited Rating ☆☆ Risk Moderately High Expense Ratio 2.46 Sharpe Ratio 1.01 Information Ratio -0.53 Alpha Ratio -1.07 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 31 May 22 ₹11,235 31 May 23 ₹12,466 Returns for IDBI Diversified Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 2.4% 3 Month 10.2% 6 Month 13.2% 1 Year 13.5% 3 Year 22.7% 5 Year 12% 10 Year 15 Year Since launch 15.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Fund Manager information for IDBI Diversified Equity Fund
Name Since Tenure Data below for IDBI Diversified Equity Fund as on 30 Jun 23
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 7. Kotak Global Emerging Market Fund
Kotak Global Emerging Market Fund
Growth Launch Date 26 Sep 07 NAV (09 Jun 26) ₹40.482 ↑ 1.34 (3.43 %) Net Assets (Cr) ₹1,540 on 30 Apr 26 Category Equity - Global AMC Kotak Mahindra Asset Management Co Ltd Rating ☆☆☆ Risk High Expense Ratio 1.64 Sharpe Ratio 2.14 Information Ratio -0.38 Alpha Ratio -2.33 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 31 May 22 ₹8,527 31 May 23 ₹8,025 31 May 24 ₹9,225 31 May 25 ₹10,133 31 May 26 ₹17,663 Returns for Kotak Global Emerging Market Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 2.2% 3 Month 24.5% 6 Month 33.7% 1 Year 64.4% 3 Year 27% 5 Year 11.4% 10 Year 15 Year Since launch 7.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.1% 2023 5.9% 2022 10.8% 2021 -15% 2020 -0.5% 2019 29.1% 2018 21.4% 2017 -14.4% 2016 30.4% 2015 -1.2% Fund Manager information for Kotak Global Emerging Market Fund
Name Since Tenure Arjun Khanna 9 May 19 7.07 Yr. Data below for Kotak Global Emerging Market Fund as on 30 Apr 26
Equity Sector Allocation
Sector Value Technology 35.06% Financial Services 20.26% Consumer Cyclical 12.1% Industrials 9.64% Basic Materials 6.38% Communication Services 5.81% Energy 5.79% Health Care 2.14% Consumer Defensive 1.41% Asset Allocation
Asset Class Value Cash 1.41% Equity 98.59% Top Securities Holdings / Portfolio
Name Holding Value Quantity CI Emerging Markets Class A
Investment Fund | -101% ₹1,551 Cr 4,488,378
↑ 1,351,712 Net Current Assets/(Liabilities)
Net Current Assets | -2% -₹38 Cr Triparty Repo
CBLO/Reverse Repo | -2% ₹28 Cr 8. IDBI Hybrid Equity Fund
IDBI Hybrid Equity Fund
Growth Launch Date 24 Oct 16 NAV (28 Jul 23) ₹17.1253 ↓ -0.01 (-0.05 %) Net Assets (Cr) ₹179 on 30 Jun 23 Category Hybrid - Hybrid Equity AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.52 Sharpe Ratio 1.03 Information Ratio -1.03 Alpha Ratio -0.26 Min Investment 5,000 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 31 May 22 ₹10,371 31 May 23 ₹11,318 Returns for IDBI Hybrid Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 2.1% 3 Month 7.8% 6 Month 9.8% 1 Year 12.1% 3 Year 14.4% 5 Year 7.1% 10 Year 15 Year Since launch 8.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Fund Manager information for IDBI Hybrid Equity Fund
Name Since Tenure Data below for IDBI Hybrid Equity Fund as on 30 Jun 23
Asset Allocation
Asset Class Value Equity Sector Allocation
Sector Value Debt Sector Allocation
Sector Value Credit Quality
Rating Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 9. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (10 Jun 26) ₹309.984 ↓ -1.33 (-0.43 %) Net Assets (Cr) ₹1,144 on 30 Apr 26 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.26 Sharpe Ratio 0.24 Information Ratio -0.12 Alpha Ratio 1.95 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 31 May 22 ₹9,076 31 May 23 ₹9,544 31 May 24 ₹14,035 31 May 25 ₹17,397 31 May 26 ₹19,319 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 2% 3 Month 9.8% 6 Month 8.9% 1 Year 9.9% 3 Year 26.1% 5 Year 13.9% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 -3.1% 2023 42.9% 2022 38.2% 2021 -12.3% 2020 19.1% 2019 67.4% 2018 1.2% 2017 -7.5% 2016 6.2% 2015 -9.7% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 4.08 Yr. Data below for UTI Healthcare Fund as on 30 Apr 26
Equity Sector Allocation
Sector Value Health Care 94.69% Basic Materials 0.57% Asset Allocation
Asset Class Value Cash 4.75% Equity 95.25% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA9% ₹108 Cr 600,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323316% ₹67 Cr 236,511
↓ -4,345 Lupin Ltd (Healthcare)
Equity, Since 28 Feb 25 | 5002574% ₹48 Cr 210,000
↓ -60,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹40 Cr 53,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹39 Cr 60,738 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322963% ₹38 Cr 159,440
↓ -40,560 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY3% ₹38 Cr 290,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹38 Cr 215,251 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹37 Cr 400,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM3% ₹37 Cr 68,000 10. ICICI Prudential US Bluechip Equity Fund
ICICI Prudential US Bluechip Equity Fund
Growth Launch Date 6 Jul 12 NAV (09 Jun 26) ₹74.79 ↑ 0.65 (0.88 %) Net Assets (Cr) ₹3,607 on 30 Apr 26 Category Equity - Global AMC ICICI Prudential Asset Management Company Limited Rating ☆☆☆☆ Risk High Expense Ratio 2.06 Sharpe Ratio 1.98 Information Ratio -1.59 Alpha Ratio 3.03 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-3 Months (3%),3-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 31 May 22 ₹10,042 31 May 23 ₹11,490 31 May 24 ₹13,405 31 May 25 ₹14,041 31 May 26 ₹17,557 Returns for ICICI Prudential US Bluechip Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 1.9% 3 Month 1.4% 6 Month 4.5% 1 Year 21.1% 3 Year 13.7% 5 Year 11.1% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 15.8% 2023 10.4% 2022 30.6% 2021 -7.1% 2020 22.5% 2019 18.6% 2018 34.3% 2017 5.2% 2016 14.1% 2015 11.6% Fund Manager information for ICICI Prudential US Bluechip Equity Fund
Name Since Tenure Ritesh Lunawat 13 Sep 24 1.72 Yr. Sharmila D'Silva 1 Jul 22 3.92 Yr. Nitya Mishra 4 Nov 24 1.57 Yr. Data below for ICICI Prudential US Bluechip Equity Fund as on 30 Apr 26
Equity Sector Allocation
Sector Value Technology 27.88% Consumer Defensive 17.23% Industrials 15.96% Health Care 15.49% Financial Services 9.5% Consumer Cyclical 7.13% Communication Services 2.46% Basic Materials 1.26% Real Estate 0.97% Asset Allocation
Asset Class Value Cash 2.13% Equity 97.87% Top Securities Holdings / Portfolio
Name Holding Value Quantity NXP Semiconductors NV (Technology)
Equity, Since 30 Sep 24 | NXPI3% ₹124 Cr 44,400 Kenvue Inc (Consumer Defensive)
Equity, Since 31 Mar 24 | KVUE3% ₹95 Cr 568,560 Clorox Co (Consumer Defensive)
Equity, Since 30 Jun 25 | CLX3% ₹92 Cr 100,000
↑ 7,200 United Parcel Service Inc Class B (Industrials)
Equity, Since 30 Sep 24 | UPS3% ₹91 Cr 88,273 Constellation Brands Inc Class A (Consumer Defensive)
Equity, Since 31 Dec 24 | STZ3% ₹91 Cr 60,700 Tyler Technologies Inc (Technology)
Equity, Since 30 Sep 25 | TYL3% ₹90 Cr 27,783 Microsoft Corp (Technology)
Equity, Since 30 Jun 16 | MSFT2% ₹89 Cr 22,897 Salesforce Inc (Technology)
Equity, Since 31 Dec 18 | CRM2% ₹88 Cr 52,495 Airbnb Inc Ordinary Shares - Class A (Consumer Cyclical)
Equity, Since 30 Sep 25 | ABNB2% ₹86 Cr 63,993 Otis Worldwide Corp Ordinary Shares (Industrials)
Equity, Since 30 Sep 25 | OTIS2% ₹85 Cr 114,100 11. Sundaram Equity Hybrid Fund
Sundaram Equity Hybrid Fund
Growth Launch Date 23 Jun 00 NAV (31 Dec 21) ₹135.137 ↑ 0.78 (0.58 %) Net Assets (Cr) ₹1,954 on 30 Nov 21 Category Hybrid - Hybrid Equity AMC Sundaram Asset Management Company Ltd Rating ☆☆ Risk Moderately High Expense Ratio 2.18 Sharpe Ratio 2.64 Information Ratio -0.12 Alpha Ratio 5.81 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 21 ₹10,000 Returns for Sundaram Equity Hybrid Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jan 22 Duration Returns 1 Month 1.8% 3 Month 0.5% 6 Month 10.5% 1 Year 27.1% 3 Year 16% 5 Year 14.2% 10 Year 15 Year Since launch 12.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Fund Manager information for Sundaram Equity Hybrid Fund
Name Since Tenure Data below for Sundaram Equity Hybrid Fund as on 30 Nov 21
Asset Allocation
Asset Class Value Equity Sector Allocation
Sector Value Debt Sector Allocation
Sector Value Credit Quality
Rating Value Top Securities Holdings / Portfolio
Name Holding Value Quantity
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തിയിട്ടുണ്ട്. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് യാതൊരു ഉറപ്പും നൽകുന്നില്ല. എന്തെങ്കിലും നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് സ്കീം വിവര രേഖ ഉപയോഗിച്ച് പരിശോധിക്കുക.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2026 Shepard Technologies Private Limited. All Rights Reserved
Research Highlights for HDFC Long Term Advantage Fund